Company
Deep Genomics recruits from among the top 1% of recent graduates and seasoned experts at the intersection of genomics, drug development and AI.

Interdisciplinary Team

Deep Genomics has over 40 team members, with expertise in artificial intelligence, automation, cell and molecular biology, clinical development, in vitro disease models, machine learning, medicine, molecular genetics, preclinical development, organic chemistry and software engineering.

Brendan Frey, PhD, FRSC

FOUNDER & CHIEF EXECUTIVE OFFICER

Brendan led the launch of Deep Genomics in 2015, to address the need for a new data- and AI-driven approach to the detection and treatment of genetic disease. He is responsible for the development and performance of our AI Workbench and for empowering our team to discover, develop and market genetic medicines, both rapidly and with a high rate of success. He was a pioneer in developing AI systems that could accurately predict normal and pathological cell biology, and over the past 15 years led projects that were described in Nature, Nature Biotechnology, Science and Cell. His co-inventions include one of the first deep learning algorithms (1995), factor graphs (1997), a coding method that helped to form the 802.11 Wi-Fi standard (1999), the affinity propagation clustering algorithm (2007), and deep learning models of splicing (2015, 2018), protein-DNA/RNA interaction (2015) and polyadenylation (2017). Brendan holds numerous distinctions and is a Professor of Engineering and Medicine at the University of Toronto, a Co-Founder of the Vector Institute for Artificial Intelligence, a Senior Fellow of the Canadian Institute for Advanced Research, and a Fellow of the Royal Society of Canada, the IEEE and the AAAS.

Advisors

Our advisors have built the most successful life science and information technology companies and are world-leading experts in their fields. Here are some of them.

Arthur A. Levin

EVP Research & Development, Avidity Biosciences

Perter Barton Hutt

Senior Counsel, Covington & Burling; Former Chief Counsel, FDA

Steven F. Dowdy

Professor of Medicine, University of California at San Diego

Steve Jurvetson

Co-Founder, Future Ventures
Board Member, SpaceX, Tesla

Vinod Khosla

Founder, Khosla Ventures; Co-Founder, Sun Microsystems

Benjamin Neale

Professor, Massachusetts General Hospital, Harvard Medical School and Broad Institute

Vern Norviel

Partner, Wilson Sonsini Goodrich and Rosati; Adjunct Professor, UC Berkeley

Eric G. Marcusson

Founder, Marcusson Consulting; CSO, Providence Therapeutics

Yann LeCun

Chief AI Scientist, Facebook; Professor, New York University

Investors

VENTURES

true0bentures

BB



future ventures



amplitude

     magnetic_grayscale

Offices

Deep Genomics is located in the heart of Toronto, the fastest growing tech hub in North America and widely recognized as one of the most livable cities in the world. Our facilities span experimental biology and computational analysis. We are located in the MaRS tower, right beside the University of Toronto, four research hospitals, three medical research institutes, and the AI research labs of Google, Uber and the Vector Institute for Artificial Intelligence.